A Prospective Virtual Study to Evaluate the Longevity of IgG Antibodies in Individuals Exposed to COVID-19

Clinical trial NCT05042193 · COMPLETED

Trial details

NCT number: NCT05042193
Sponsor: Everly Health
Status: COMPLETED
Study type: OBSERVATIONAL

SARS-CoV-2 Acute Respiratory Disease

Start date: 2021-03-19
Primary completion: 2022-05-31
Enrollment: 1883

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.